PubMed for id: 1001

Year	Number of Results
1989	2
1991	1
1992	1
1993	1
1994	4
1995	2
1996	1
1997	4
1998	1
1999	2
2000	4
2001	2
2002	8
2003	3
2004	3
2005	5
2007	3
2008	9
2009	9
2010	13
2011	7
2012	7
2013	8
2014	6
2015	4
2016	10
2017	5
2018	5
2019	5
2020	10
2021	7
2022	6
2023	1
2024	0

1

Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma.

Faraj Tabrizi P, Peters I, Schimansky I, Dubrowinskaja N, Reese C, Tezval H, Kuczyk MA, Serth J. Faraj Tabrizi P, et al. Int J Mol Sci. 2023 Nov 18;24(22):16476. doi: 10.3390/ijms242216476. Int J Mol Sci. 2023. PMID: 38003666 Free PMC article.

2

Novel compound heterozygous cadherin 3 mutations in hypotrichosis and juvenile macular dystrophy.

Ren Y, Liu J, Yao D, Hua H, Guo X, Dai H, Dang N, Huang Y, Yu D. Ren Y, et al. Chin Med J (Engl). 2022 Jun 20;135(12):1503-1505. doi: 10.1097/CM9.0000000000002190. Chin Med J (Engl). 2022. PMID: 35853629 Free PMC article. No abstract available.

3

CDH3 is associated with poor prognosis by promoting the malignancy and chemoresistance in oral squamous cell carcinoma.

Wu T, Xiao Z, Li Y, Jiao Z, Liang X, Zhang Y, Liu H, Yang A. Wu T, et al. Asian J Surg. 2022 Dec;45(12):2651-2658. doi: 10.1016/j.asjsur.2022.01.075. Epub 2022 Mar 17. Asian J Surg. 2022. PMID: 35305877 Free article.

4

Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.

Martins EP, Gonçalves CS, Pojo M, Carvalho R, Ribeiro AS, Miranda-Gonçalves V, Taipa R, Pardal F, Pinto AA, Custódia C, Faria CC, Baltazar F, Sousa N, Paredes J, Costa BM. Martins EP, et al. Mol Oncol. 2022 Jul;16(14):2611-2631. doi: 10.1002/1878-0261.13162. Epub 2022 Jun 10. Mol Oncol. 2022. PMID: 34919784 Free PMC article.

5

Placental-Cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinoma.

Wang H, Yu T, Mao L. Wang H, et al. Eur Arch Otorhinolaryngol. 2022 Jul;279(7):3597-3609. doi: 10.1007/s00405-021-07181-x. Epub 2021 Nov 26. Eur Arch Otorhinolaryngol. 2022. PMID: 34825969

6

Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study.

Kayahashi K, Mizumoto Y, Matsuoka A, Obata T, Iwadare J, Nakamura M, Daikoku T, Fujiwara H. Kayahashi K, et al. BMC Cancer. 2021 Jan 7;21(1):32. doi: 10.1186/s12885-020-07737-w. BMC Cancer. 2021. PMID: 33413178 Free PMC article.

7

P-cadherin induces anoikis-resistance of matrix-detached breast cancer cells by promoting pentose phosphate pathway and decreasing oxidative stress.

Sousa B, Pereira J, Marques R, Grilo LF, Pereira SP, Sardão VA, Schmitt F, Oliveira PJ, Paredes J. Sousa B, et al. Biochim Biophys Acta Mol Basis Dis. 2020 Dec 1;1866(12):165964. doi: 10.1016/j.bbadis.2020.165964. Epub 2020 Sep 10. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32920119 Free article.

8

Phase I Study of P-cadherin-targeted Radioimmunotherapy with ⁹⁰Y-FF-21101 Monoclonal Antibody in Solid Tumors.

Subbiah V, Erwin W, Mawlawi O, McCoy A, Wages D, Wheeler C, Gonzalez-Lepera C, Liu H, Macapinlac H, Meric-Bernstam F, Hong DS, Pant S, Le D, Santos E, Gonzalez J, Roszik J, Suzuki T, Subach RA, Madden T, Johansen M, Nomura F, Satoh H, Matsuura T, Kajita M, Nakamura E, Funase Y, Matsushima S, Ravizzini G. Subbiah V, et al. Clin Cancer Res. 2020 Nov 15;26(22):5830-5842. doi: 10.1158/1078-0432.CCR-20-0037. Epub 2020 Aug 18. Clin Cancer Res. 2020. PMID: 32816889 Clinical Trial.

9

Integrative Omics Analysis Reveals Soluble Cadherin-3 as a Survival Predictor and an Early Monitoring Marker of EGFR Tyrosine Kinase Inhibitor Therapy in Lung Cancer.

Hsiao TF, Wang CL, Wu YC, Feng HP, Chiu YC, Lin HY, Liu KJ, Chang GC, Chien KY, Yu JS, Yu CJ. Hsiao TF, et al. Clin Cancer Res. 2020 Jul 1;26(13):3220-3229. doi: 10.1158/1078-0432.CCR-19-3972. Epub 2020 Mar 10. Clin Cancer Res. 2020. PMID: 32156745

10

Correlating Adaptive Optics Images to Clinical Findings in Juvenile Macular Dystrophy with Hypotrichosis in Siblings with Homozygous CDH3 Pathogenic Variation.

Nasser F, Kempf M, Kurtenbach A, Stöhr H, Weber BHF, Neuhaus C, Rating P, Zrenner E. Nasser F, et al. Ophthalmic Res. 2020;63(2):141-151. doi: 10.1159/000504757. Epub 2020 Jan 10. Ophthalmic Res. 2020. PMID: 31927556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

146 results

Results by year